Program – 2025

The 2025 Workshop Program (below) is under development.
Program is subject to change. 

FRIDAY , JULY 18

Workshop Pretest available, to be completed by 2 p.m. on Sunday, July 20

SUNDAY, JULY 20

Registration
2-8 pm

Faculty Meeting
4:15-5:15 pm

Welcome/Overview
5:15-5:30 pm

  • Julie M. Vose, University of Nebraska Medical Center, Omaha, Nebraska
  • Wendy B. London, Dana-Farber Cancer Institute and Boston Children’s Hospital, Boston, Massachusetts
  • Timothy A. Yap, The University of Texas Anderson Cancer Center, Houston, Texas

Lecture Session 1
5:30-6 pm

  • Answering Important Questions: From Hypothesis to Analysis
    Wendy B. London, Dana-Farber Cancer Institute and Boston Children’s Hospital, Boston, Massachusetts

Protocol Development Group Session 1 / Grab and Go Dinner
6-8 pm

MONDAY, JULY 21

Breakfast
7-8 am

Lecture Session 2
8-9:50 am

  • Phase I Trial Designs and Questions
    Alex A. Adjei, Cleveland Clinic, Cleveland, OH and Shing Lee, Columbia University, New York, New York
  • Phase II Trial Designs, Questions, and Objectives
    Maha Hussain, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • Questions / Panel Discussion
  • TAKE NOTE: How will this session be applied to your protocol

Break
9:50-10 am

Lecture Session 3
10-11:40 am

  • Combination and Multimodality Trials
    Hope Rugo, City of Hope, Duarte Cancer Center, Duarte, California
    Amir Jazaeri, University of Texas, MD Anderson Cancer Center, Houston Texas
    Adam P. Dicker, Thomas Jefferson University, Philadelphia, Pennsylvania
  • Project Optimus: Reforming Dose Optimization and Dose Selection
    Timothy A. Yap, The University of Texas Anderson Cancer Center, Houston, Texas
  • Questions / Panel Discussion
  • TAKE NOTE: How will this session be applied to your protocol

Group Writing Session 1
11:40 am – 12:30 pm

Lunch
12-1:30 pm

Protocol Development Group Session 2 / Grab and Go Lunch
12:30-2:45 pm

Office Hours 1: Biostatistician Faculty Only (Prescheduled Appointments, with PDG Biostatistician Faculty)
3-5:15 pm

Dinner (Including Team-Building Exercise)
7-9 pm

ASSIGNMENT DUE: PROTOCOL TEMPLATE
8 pm

TUESDAY, JULY 22

Breakfast
7-8 am

Lecture Session 4
8-9:45 am

  • Incorporation of Biological Correlative Studies into Early Clinical Trials
    Jordi Rodon Ahnert, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Feasibility and Reproducibility in Biomarker Studies
    Kurt A. Schalper, Yale University, New Haven, Connecticut
  • Statistical Aspects of Correlative Studies
    Statistician to be announced
  • Questions / Panel Discussion
  • TAKE NOTE: How will this session be applied to your protocol

Break
9:40-10 am

Lecture Session 5
10-11:15 am

  • Imaging in the Era of Targeted Therapy and Immunotherapy
    Ammar Chaudhry, AstraZeneca, Yorba Linda, California
  • Special Considerations in the Design of Immunotherapy Studies
    Ryan Sullivan, Harvard Medical School/Massachusetts General Hospital, Boston, Massachusetts
  • Questions / Panel Discussion
  • TAKE NOTE: How will this session be applied to your protocol

Group Writing Session 2
11:15 am-12 pm

Lunch
12-1:15 pm

Protocol Development Group Session 3
1:15-4 pm

Office Hours 2: Statistical Design and Protocol Related Questions
4:15-6:30 pm

Grab and Go Dinner
5:30-7 pm

ASSIGNMENT DUE: STATISTICAL DESIGN
7 pm

WEDNESDAY, JULY 23

Breakfast
7-8 am

Small Group Discussion Sessions 1-3
8-9 am

  • Elements of Artificial Intelligence
    Carole Baas, NCI Physical Sciences in Oncology Network, Southlake, Texas
    Ammar Chaudhry, AstraZeneca, Yorba Linda, California
    John Rice, University of Michigan, Ann Arbor, Michigan
  • Symptom Management, Patient Reported Outcomes, and Quality of Life
    Vijaya R. Bhatt, University of Nebraska Medical Center, Omaha, Nebraska
    Jill Feldman, EGFR Resisters, Evanston, Illinois
    Sujata Patil, Cleveland Clinic, Cleveland, Ohio
  • Laboratory Correlates, ctDNA, and Liquid Biopsy
    Maura N. Dickler, Genentech, South San Francisco, California
    Josh Mailman, NorCal CarciNET Community, Oakland, California
    Lindsay Renfro, University of Southern California, Los Angeles, California

Break
9-9:15 am

Small Group Discussion Sessions 4-6
9:15-10:15 am

  • Elements of Artificial Intelligence
    Carole Baas, NCI Physical Sciences in Oncology Network, Southlake, Texas
    Ammar Chaudhry, AstraZeneca, Yorba Linda, California
    John Rice, University of Michigan, Ann Arbor, Michigan
  • Symptom Management, Patient Reported Outcomes, and Quality of Life
    Vijaya R. Bhatt, University of Nebraska Medical Center, Omaha, Nebraska
    Jill Feldman, EGFR Resisters, Evanston, Illinois
    Sujata Patil, Cleveland Clinic, Cleveland, Ohio
  • Laboratory Correlates, ctDNA, and Liquid Biopsy
    Maura N. Dickler, Genentech, South San Francisco, California
    Josh Mailman, NorCal CarciNET Community, Oakland, California
    Lindsay Renfro, University of Southern California, Los Angeles, California

Break / Group Photo
10:15-10:45 am

Protocol Development Group Session 4
10:45 am-1:15 pm

Lunch
1:15 pm-2:15 pm

Office Hours 3: Protocol Related Questions
2:15 pm-4:30 pm

Free Time / Dinner on Own
2:30 pm

ASSIGNMENT DUE: PROTOCOL DRAFTS
7 pm

THURSDAY, JULY 24

Breakfast
7-8 am

Lecture Session 6
8-9:45 am

  • You’re in Charge: Investigator Responsibilities
    John P. Leonard, NYU Langone, New York, New York
  • How to Pay for Your Trial
    Richard D. Carvajal, Northwell Health Cancer Institute, New York, New York
  • Everything You Need to Know About Clinical Trial Ethics and Informed Consent
    Diana T. Chingos, DTC Consulting, Los Angeles, California
  • Questions / Panel Discussion
  • TAKE NOTE: How will this session be applied to your protocol

Break
9:45-10 am

Protocol Development Group Session 5
10 am – 12:30 pm

Lunch
12:30-1:30 pm

Independent Study Time/Dinner on Own
3-7 pm

Office Hours 4: Informed Consent and Protocol Related Questions
1:30-3:30 pm

Free Time / Dinner on Own
3:30 pm

ASSIGNMENT DUE: INFORMED CONSENT DOCUMENTS
7 pm

FRIDAY, JULY 25

Breakfast
7-8:30 am

Faculty Meeting (Faculty Only)
7-8 am

Lecture Session 7
8:30-10:15 am

  • Successful Grantsmanship
    Mark Krailo, Children’s Oncology Group, Los Angeles, California
  • Data Collection: It’s All in the Data
    To be announced
  • Reporting and Presenting Results
    Tari King, Dana-Farber Cancer Institute/Brigham and Women’s Cancer Center, Boston, Massachusetts
    Mary W. Redman, Fred Hutchinson Cancer Center, Seattle, Washington
  • Questions / Panel Discussion

Protocol Development Group Session 6
10:30 am-12 pm

Lunch (Boxed)
12-1:30 pm

Office Hours 5: Professional Development: Careers, Funding, and Publications
1:30-2:45 pm

Administration of Post-test
1-7 pm

Free Time
1:30-7 pm

Optional Networking Reception: Women in Hematology/Oncology
5-6 pm

ASSIGNMENT DUE: FINAL PROTOCOLS, INFORMED CONSENT FORMS, and ALL WORKSHOP EVALUATIONS
7 pm

Closing Reception / Banquet / Dance
7-11 pm

SATURDAY, JULY 26

Departure (on own)